Barclays PLC Precigen, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Precigen, Inc. stock. As of the latest transaction made, Barclays PLC holds 189,353 shares of PGEN stock, worth $213,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,353

Previous 189,353 -0.0%

Holding current value

$213,968

Previous $179,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$0.91 - $1.88 $112,968 - $233,385	124,141 Added 190.37%	189,353 $179,000
Q2 2024 Aug 14, 2024	SELL	$1.27 - $1.75 $61,066 - $84,147	-48,084 Reduced 42.44%	65,212 $104,000
Q1 2024 May 15, 2024	SELL	$1.21 - $1.75 $112,825 - $163,177	-93,244 Reduced 45.15%	113,296 $164,000
Q4 2023 Feb 15, 2024	BUY	$0.89 - $1.41 $143,688 - $227,641	161,448 Added 358.04%	206,540 $276,000
Q3 2023 Nov 07, 2023	SELL	$1.08 - $1.85 $4,065 - $6,963	-3,764 Reduced 7.7%	45,092 $64,000
Q2 2023 Aug 03, 2023	SELL	$0.96 - $1.4 $33,249 - $48,489	-34,635 Reduced 41.48%	48,856 $55,000
Q1 2023 May 04, 2023	BUY	$0.88 - $2.19 $30,345 - $75,519	34,484 Added 70.37%	83,491 $88,000
Q4 2022 Feb 13, 2023	BUY	$1.27 - $2.26 $28,985 - $51,579	22,823 Added 87.16%	49,007 $74,000
Q3 2022 Nov 03, 2022	BUY	$1.41 - $2.79 $29,770 - $58,908	21,114 Added 416.45%	26,184 $55,000
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $5,824 - $12,814	5,065 Added 101300.0%	5,070 $7,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $9 - $19	5 New	5 $0

Others Institutions Holding PGEN

# of Institutions

142

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $235M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account